Tri Locum Partners LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Tri Locum Partners LP disclosed 28 US equity positions worth $482.7m in its Q4 2024 13F filing. The largest position was TEVA at 11.1% of the reported book, followed by ZBH and ARGX. Against the Q3 2024 filing, it opened 12 new positions, added to 7 and reduced 7 among the top 28 holdings.
What did Tri Locum Partners LP own in Q4 2024? Top 28 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 11.1% | $53.4m | 2,423,116 | -12% | reduced |
| 2 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 8.1% | $39.0m | 369,004 | – | new |
| 3 | ARGX ARGENX SE | Healthcare | 7.4% | $35.8m | 58,258 | -7% | reduced |
| 4 | NTRA NATERA INC | Healthcare | 6.6% | $32.1m | 202,646 | -36% | reduced |
| 5 | INSP INSPIRE MED SYS INC | Healthcare | 5.8% | $28.0m | 150,788 | -0% | held |
| 6 | STVN STEVANATO GROUP S P A | 5.1% | $24.4m | 1,121,804 | -40% | reduced | |
| 7 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 4.4% | $21.1m | 249,769 | 172% | added |
| 8 | VRNA VERONA PHARMA PLC | 4.4% | $21.1m | 454,201 | -24% | reduced | |
| 9 | AVADEL PHARMACEUTICALS PLC | 4.2% | $20.4m | 1,937,984 | 17% | added | |
| 10 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 4.2% | $20.1m | 355,366 | – | new |
| 11 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 4.1% | $19.9m | 161,812 | – | new |
| 12 | IDXX IDEXX LABS INC | Healthcare | 3.9% | $18.6m | 44,972 | – | new |
| 13 | NVO NOVO-NORDISK A S | Healthcare | 3.7% | $18.1m | 209,984 | 212% | added |
| 14 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 3.0% | $14.6m | 47,472 | 10% | added |
| 15 | MERUS N V | 3.0% | $14.6m | 347,303 | 81% | added | |
| 16 | UNH UNITEDHEALTH GROUP INC | Healthcare | 2.9% | $14.2m | 28,115 | – | new |
| 17 | JANX JANUX THERAPEUTICS INC | Healthcare | 2.6% | $12.7m | 236,407 | – | new |
| 18 | LEGN LEGEND BIOTECH CORP | Healthcare | 2.6% | $12.6m | 388,704 | 7% | added |
| 19 | CI THE CIGNA GROUP | Healthcare | 2.3% | $11.3m | 40,810 | – | new |
| 20 | WGS GENEDX HOLDINGS CORP | Healthcare | 2.0% | $9.8m | 127,567 | – | new |
| 21 | GERN GERON CORP | Healthcare | 1.8% | $8.8m | 2,472,836 | – | new |
| 22 | EOLS EVOLUS INC | Healthcare | 1.7% | $8.2m | 742,574 | – | new |
| 23 | BRD1EUR MIND MEDICINE MINDMED INC | 1.2% | $5.7m | 820,793 | -51% | reduced | |
| 24 | KRRO KORRO BIO INC | Healthcare | 1.1% | $5.5m | 144,216 | 125% | added |
| 25 | BHVN BIOHAVEN LTD | Healthcare | 1.1% | $5.2m | 140,220 | -27% | reduced |
| 26 | LIVN LIVANOVA PLC | Healthcare | 1.0% | $4.6m | 99,700 | – | new |
| 27 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.6% | $2.9m | 37,269 | – | new |
| 28 | FEMY FEMASYS INC | 0.0% | $33.7k | 30,606 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.